Immunohistochemical expression of stem cell markers CD133 and Oct4 in colorectal adenocarcinoma
In conclusion, we show that Oct4 may play a role in colorectal adenocarcinoma development and progression, and we suggest its utilization as a significant prognostic marker in colorectal carcinoma patients.
Source: Egyptian Journal of Pathology - Category: Pathology Tags: Original Articles Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Colon Cancer | Colorectal Cancer | Pathology | Stem Cell Therapy | Stem Cells